Following recovery from the impact of the COVID-19 pandemic, the European neurostimulation device market will see modest growth through 2032, driven by ongoing product innovation and a focus on…
The US neurostimulation device market is characterized by ongoing product innovation; iterative device improvements are regularly launching in established segments—such as the SCS and DBS device…
A large undiagnosed patient population, rising PVD diagnosis rates, and growth in endovascular procedure volumes will support continued growth in the Latin American PV device market; however, cost…
The US IC device market is facing intense pricing pressure on established products, such as DES, limiting the overall market growth. However, steady uptake of novel, premium technologies has…
Over the forecast period, Latin American spinal implant market expansion will be driven by procedure volume growth due to an aging population and uptake of premium innovations such as 3-D–…
The US reconstructive small-joint implant market has largely recovered from the negative impacts of the COVID-19 pandemic and will resume prepandemic growth trends in the near term; going forward,…
The Japanese TEO device market will see modest growth over the forecast period driven by growing adoption of minimally invasive treatment options like embolization, increasing product launches, and…
The US cardiac assist device market will continue to experience growth after recovering from the impact of the COVID-19 pandemic. The market will be driven by expanded use of cardiac assist devices…
The US vascular access device market will grow slowly over the forecast period. On one hand, unit sales will be supported by steady growth in the underlying patient population undergoing medical…
The US PV device market will be driven by the continued rise in adoption of various endovascular treatment techniques and innovative product launches supported by favorable reimbursement programs,…
The US pain management device market is characterized by ongoing product innovation to improve treatment efficacy and to address new indications, with new clinical evidence and pain management…
The Asia Pacific TEO device market will see moderate growth through 2032 driven by the launch and increasing adoption of new devices backed by favorable clinical data, increasing access to the TEO…
The global laparoscopic surgical robotic device market has shown strong recovery from the impacts of the COVID-19 pandemic and is anticipated to resume prepandemic growth trends in the near term,…
Driven by the increasing prevalence of kidney conditions in this region, the market for Japanese urological devices will continue to expand through 2032, despite the negative impact of the COVID-19…